Figure 1. CMV viral load to start preemptive therapy (PET) used at the FHCRC in Seattle, WA, and the Karolinska Institute, Stockholm, Sweden.
Figure 1

CMV viral load to start preemptive therapy (PET) used at the FHCRC in Seattle, WA, and the Karolinska Institute, Stockholm, Sweden.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal